These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 2427760
1. Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats. Iwaki M, Ino Y, Motoyoshi A, Ozeki M, Sato T, Kurumi M, Aoyama T. Jpn J Pharmacol; 1986 Jun; 41(2):155-62. PubMed ID: 2427760 [Abstract] [Full Text] [Related]
2. [Pharmacological studies of FUT-175, nafamstat mesilate. II. Effects on experimental acute pancreatitis]. Iwaki M, Ozeki M, Sato T, Suzuki K, Motoyoshi A, Suzuki S, Fujita M, Aoyama T. Nihon Yakurigaku Zasshi; 1984 Oct; 84(4):363-72. PubMed ID: 6210233 [Abstract] [Full Text] [Related]
3. [Comparative studies of nafamostat mesilate and various serine protease inhibitors in vitro]. Ino Y, Suzuki K, Sato T, Iwaki M. Nihon Yakurigaku Zasshi; 1986 Dec; 88(6):449-55. PubMed ID: 2435641 [Abstract] [Full Text] [Related]
4. Nafamostat mesilate on the course of acute pancreatitis. Protective effect on peritoneal permeability and relation with supervening pulmonary distress. Marotta F, Fesce E, Rezakovic I, Chui DH, Suzuki K, Idéo G. Int J Pancreatol; 1994 Aug; 16(1):51-9. PubMed ID: 7528762 [Abstract] [Full Text] [Related]
5. The effect of nafamostat mesilate (FUT-175) and gabexate mesilate (FOY) on multiorgan oxidant-antioxidant balance in acute experimental pancreatitis. Dabrowski A, Gabryelewicz A. J Physiol Pharmacol; 1994 Sep; 45(3):455-65. PubMed ID: 7841457 [Abstract] [Full Text] [Related]
6. Activation of trypsinogen in experimental models of acute pancreatitis in rats. Nakae Y, Naruse S, Kitagawa M, Hirao S, Yamamoto R, Hayakawa T. Pancreas; 1995 Apr; 10(3):306-13. PubMed ID: 7542773 [Abstract] [Full Text] [Related]
7. [Effects of E-3123, a new protease inhibitor, on several protease activities and on experimental acute pancreatitis]. Miyamoto K, Hishinuma I, Nagakawa J, Nagaoka N, Yamanaka T, Wakabayashi T. Nihon Yakurigaku Zasshi; 1988 May; 91(5):285-93. PubMed ID: 3410375 [Abstract] [Full Text] [Related]
8. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis. Manabe T, Hirano T, Imanishi K, Ando K, Yotsumoto F, Tobe T. Int J Pancreatol; 1992 Oct; 12(2):167-72. PubMed ID: 1281204 [Abstract] [Full Text] [Related]
9. The effects of nafamostat mesilate (FUT-175) on caerulein-induced acute pancreatitis in the rat. Wisner JR, Ozawa S, Renner IG. Int J Pancreatol; 1989 May; 4(4):383-90. PubMed ID: 2732529 [Abstract] [Full Text] [Related]
10. [Therapeutic effects of human urinary trypsin inhibitor on acute experimental pancreatitis]. Ohnishi H, Kosuzume H, Ashida Y, Kato K, Suzuki Y, Honjo I. Nihon Yakurigaku Zasshi; 1983 Mar; 81(3):235-44. PubMed ID: 6345304 [Abstract] [Full Text] [Related]
11. Therapeutic regimens in acute experimental pancreatitis in rats: effects of a protease inhibitor, a beta-agonist, and antibiotics. Araida T, Frey CF, Ruebner B, Carlson J, King J. Pancreas; 1995 Aug; 11(2):132-40. PubMed ID: 7479669 [Abstract] [Full Text] [Related]
12. [Pharmacokinetics studies of nafamostat mesilate (FUT), a synthetic protease inhibitor, which has been used for the treatments of DIC and acute pancreatitis, and as an anticoagulant in extracorporeal circulation]. Tsukagoshi S. Gan To Kagaku Ryoho; 2000 May; 27(5):767-74. PubMed ID: 10832450 [Abstract] [Full Text] [Related]
13. Synthetic antiproteases in acute pancreatitis: an experimental study. Dobosz M, Sledziński Z, Babicki A, Juszkiewicz P, Basiński A, Wajda Z. Mt Sinai J Med; 1992 Jan; 59(1):43-6. PubMed ID: 1734237 [Abstract] [Full Text] [Related]
14. Beneficial effect of therapeutic infusion of nafamostat mesilate (FUT-175) on hemodynamics in experimental acute pancreatitis. Dobosz M, Sledzinski Z, Juszkiewicz P, Babicki A, Stanek A, Wajda Z, Basinski A. Hepatogastroenterology; 1991 Apr; 38(2):139-42. PubMed ID: 1855771 [Abstract] [Full Text] [Related]
15. [The effects of FUT-175 (nafamostat mesilate) on blood coagulation and experimental disseminated intravascular coagulation (DIC)]. Koshiyama Y, Kobori A, Ogihara M, Yokomoto Y, Ohtani K, Shimamura K, Iwaki M. Nihon Yakurigaku Zasshi; 1987 Dec; 90(6):313-20. PubMed ID: 3443413 [Abstract] [Full Text] [Related]
16. Blood platelet function in canine acute pancreatitis with reference to treatment with Nafamostat mesilate (FUT-175). Lukaszyk A, Bodzenta-Lukaszyk A, Gabryelewicz A, Bielawiec M. Thromb Res; 1992 Jan 15; 65(2):229-39. PubMed ID: 1579898 [Abstract] [Full Text] [Related]
17. Pharmacological studies of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulfonate. Effects on experimental pancreatitis. Murakami H, Togawa M, Takahashi S, Kasahara N, Yamamoto J, Matsuura N, Koshiyama Y, Ino Y, Oda M. Arzneimittelforschung; 1990 Dec 15; 40(12):1352-8. PubMed ID: 2095132 [Abstract] [Full Text] [Related]
18. [Effect of continuous arterial infusion of protease inhibitor on experimental acute pancreatitis induced by closed duodenal loop obstruction]. Kakugawa Y, Takeda K, Sunamura M, Kawaguchi S, Kobari M, Matsuno S. Nihon Shokakibyo Gakkai Zasshi; 1990 Jun 15; 87(6):1444-50. PubMed ID: 2214268 [Abstract] [Full Text] [Related]
19. Pancreatic proteases in serum induce leukocyte-endothelial adhesion and pancreatic microcirculatory failure. Keck T, Friebe V, Warshaw AL, Antoniu BA, Waneck G, Benz S, Hopt UT, Fernández-del-Castillo C. Pancreatology; 2005 Jun 15; 5(2-3):241-50. PubMed ID: 15855822 [Abstract] [Full Text] [Related]
20. Gabexate mesilate (FOY) protects against ceruletide-induced acute pancreatitis in the rat. Wisner JR, Renner IG, Grendell JH, Niederau C, Ferrell LD. Pancreas; 1987 Jun 15; 2(2):181-6. PubMed ID: 2442741 [Abstract] [Full Text] [Related] Page: [Next] [New Search]